Videos

The key opinion leaders examine the recent approval of PCV21, assessing its potential influence on pneumococcal vaccination strategies, while also identifying and discussing current unmet needs in the field of pneumococcal vaccination.

The vaccination experts analyze the impact of currently approved pneumococcal vaccines on otitis media prevention and compare the newer conjugate vaccines (PCV15 and PCV20) to their predecessors in terms of strain coverage and clinical efficacy.

Dr. Humphreys discusses operationalizing biosimilars in specialty pharmacies.

Jake Galdo and Annie Eisenbeis discuss their vaccine gap closure program and the ability to utilize the model beyond vaccines.

In an initiative to close vaccine gaps in local Missouri communities, pharmacists and community health workers proved essential.

Sophia Humphreys, PharmD, MHA, BCBBS, discusses biosimilar utilization and inventory management.

Sophia Humphreys, PharmD, MHA, BCBBS, discusses the key differences between biologics and biosimilars.

In an interview with Pharmacy Times, Jasmine Perry describes her idea of an effective health care delivery model and why research can have a huge impact at the policy level.

Key opinion leaders examine the pivotal clinical data that supported the FDA approvals of PCV15, PCV20, and PCV21, while also explaining the differences between polysaccharide and conjugate pneumococcal vaccines in terms of their induced immune responses and the durability of protection they offer.

The medical experts explore the importance of receiving PCV20 following PCV13 and PPSV23 vaccinations, while also delving into the broader discussion of how sequential administration of these pneumococcal vaccines may potentially enhance protection against targeted strains.

Drawing on years of experience, Rina Shah explains how sustainable care models are essential for a thriving pharmaceutical industry.

In an interview with Pharmacy Times, Jon Easter discusses the need for pharmacy to align as a profession to achieve policy and research goals.

President of NACDS, Steve Anderson, discusses how the events at Total Store Expo reflect on the association's goals of innovation and a focus on public policy.

Sara Roszak recounts the Annual NACDS Foundation Dinner and their role in implementing research at the clinical level.

Brandon Newman highlights the need for balanced regulation, transparency, and real-time data access to ensure fair competition and optimal outcomes for pharmacy benefit mangers.

These pharmacies bring high-touch specialty pharmacies into local communities for patients with more complex needs.

Joseph Saseen offers valuable insights into the implications of the added performance and quality measures for patients and health care providers.

Jasmine Perry discusses the More Than a Script program in an interview with Pharmacy Times.

Brandon Newman discusses the significant influence of the "big 3" pharmacy benefit managers and the key legislative and regulatory efforts around transparency.

Steve Anderson, president and CEO of the National Association of Chain Drug Stores (NACDS), discusses memorable moments from this year's NACDS Total Store Expo.

Sara Roszak discusses her role as president of the NACDS Foundation.

Scott Biggs and Doug Long explain current trends in the pharmaceutical industry and the importance of ensuring pharmacists are informed.

Jon Easter talks about community pharmacy's role in propelling diabetes innovation and optimizing patient care.

Rina Shah discusses the importance of community pharmacy and how pharmacists can optimize care for patients.

Craig Beavers discusses significance of the 2024 update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure.

The panel of experts examines the most recent ACIP recommendations for pneumococcal vaccination in adults aged 65 and older, highlighting key updates and changes to the guidelines.

Krista D. Capehart, PharmD, BCACP, FAPhA, Dr. Capeheart outlines the patient populations for whom pneumococcal vaccines are indicated and provides a detailed explanation of the ACIP-recommended immunization schedules for these vaccines.

Key opinion leaders provide pharmacists with essential guidance on the appropriate dosing and administration of over-the-counter medications for common pediatric conditions, while equipping them with strategies to effectively counsel parents on symptom identification, condition management, and when to seek medical advice for children's health issues.

A federal and state policy expert discusses the announcement from the Centers for Medicare & Medicaid Services on the agreement to lower prices for 10 selected drugs due to the Inflation Reduction Act.

Kelsea Seago, PharmD, discusses the crucial role of pharmacists in managing chimeric antigen receptor (CAR) T-cell therapy resistance.